About James Nakamura
James Nakamura is a biogerontology researcher turned science writer who has spent the better part of a decade immersed in the biology of aging — first at the bench, and now at the keyboard. After earning his Master of Science in Biogerontology from the University of Southern California's Leonard Davis School of Gerontology, one of the world's top-ranked aging research programs, James spent three years in longevity research laboratories studying the molecular mechanisms of cellular senescence and NAD+ metabolism. His bench work focused on nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) as precursors for NAD+ restoration in aging cell models, and he contributed to research exploring how senolytic and senomorphic interventions might extend healthspan in mammalian systems. It was rigorous, painstaking work — and it gave him a firsthand understanding of both the genuine promise and the significant limitations of the longevity interventions now being marketed directly to consumers.
That gap between what the science actually shows and what the supplement industry claims is what drove James into science communication. He watched as NAD+ precursors went from obscure research compounds to billion-dollar consumer supplements virtually overnight, with marketing claims that far outpaced the clinical evidence. Peptide therapies like sermorelin and BPC-157 followed a similar trajectory — enormous consumer interest, aggressive marketing, and a research base that was real but far more preliminary than most buyers realized. James wanted to be the person who could explain the actual science: what the preclinical data shows, where the human trials stand, what the mechanism of action is, and what remains genuinely unknown. He started writing for longevity-focused health publications in 2022 and quickly found his voice as a translator between the research community and the growing population of consumers interested in evidence-based anti-aging strategies.
Today, James writes about longevity science, NAD+ biology, cellular senescence, and peptide therapies for LosingWeightRX. His work is distinguished by its depth of mechanistic explanation — he doesn't just tell readers *that* something works, he explains *how* it works at the cellular and molecular level, and he's honest about where the evidence is strong, where it's emerging, and where it's simply not there yet. He brings a researcher's skepticism and a communicator's clarity to a space that desperately needs both, and he's driven by a conviction that consumers deserve to make supplement and therapy decisions based on real science rather than marketing hype.
